Here is a briefing note from SNOMED International which provides more detailed information on the outcome of the consultation on the proposal to inactivate therapeutic role groupers in the Medicinal Product hierarchy.
Please see the attached
briefing note
for further details.
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Follow-up BN on Inactivation of Therapeutic Role Groupers for Medicinal Product
Print
Email
Twitter